The potential of albumin-coated hollow mesoporous silica nanoparticles (A-HMSNs) to optimize the chemotherapeutic efficacy of docetaxel (DTX) was explored. The synthesized A-DTX-HMSNs had a nanometric size range, offered large surface area with numerous pores, and offered high drug entrapment and loading, that is, 79.18% ± 1.4% and 19.11% ± 1.30%, respectively. Fourier transform infrared spectroscopy and differential scanning calorimetry studies confirmed drug loading and the presence of albumin onto the developed systems, and the drug release followed Higuchi profile. A-HMSNs significantly enhanced the pharmacokinetic profile of DTX by eightfold vis-à-vis the pure DTX. The enhanced plasma levels (Cmax, Tmax, area under the curve), prolonged drug release, long circulation time, lower clearance, hemocompatability, and substantially higher drug loading offered by these nanocarriers inherit promise of a safer and efficacious formulation of DTX.
Get full access to this article
View all access options for this article.
References
1.
RouxLM, GueritteF: From the pacific yew (Taxus brevifolia) to the english yew (Taxus baccata): steps towards the discovery of docetaxel (Taxotere®). In:Navelbine® and Taxotere®. Le Roux M, Gueritte F (eds.), pp. 151–212. Netherlands, 2017.
2.
GustafsonDL, PageRL: Cancer chemotherapy, In: Withrow and MacEwen's Small Animal Clinical Oncology. WithrowSJ, VailDM, Page RL (eds.), pp. 157–179. WB Saunders, Saint Louis, 2013.
3.
MittalB, TulsyanS, KumarS, MittalRD, AgarwalG: Cytochrome P450 in cancer susceptibility and treatment. Adv Clin Chem, 2015; 71:77–139.
4.
CuiW, ZhangS, ZhaoH, et al.: Formulating a single thioether-bridged oleate prodrug into a self-nanoemulsifying drug delivery system to facilitate oral absorption of docetaxel. Biomater Sci, 2019; 3:1117–1131.
5.
AroraS, KumarR, KaurH, et al.: Translocation and toxicity of docetaxel multi-walled carbon nanotube conjugates in mammalian breast cancer cells. J Biomed Nanotechnol, 2014; 10:3601–3609.
6.
MahajanM, KhuranaRK, SahajpalNS, et al.: Emerging strategies and challenges for controlled delivery of taxanes: a comprehensive review. Curr Drug Metab, 2015; 16:453–473.
7.
MathurP, SharmaS, RawalS, PatelB, PatelMM: Fabrication, optimization and in vitro evaluation of docetaxel-loaded nanostructured lipid carriers for improved anticancer activity. J Liposome Res, 2019; 29:1–15.
8.
GodaraS, LatherV, KirthanashriSV, AwasthiR, PanditaD: Lipid-PLGA hybrid nanoparticles of paclitaxel: preparation, characterization, in vitro and in vivo evaluation. Mater Sci Eng C, 2020; 109:1–26.
9.
DesaleJP, SwamiR, KushwahV, KatiyarSS, JainS: Chemosensitizer and docetaxel-loaded albumin nanoparticle: overcoming drug resistance and improving therapeutic efficacy. Nanomedicine (Lond), 2018; 13:2759–2776.
10.
KushwahV, JainDK, AgrawalAK, JainS: Improved antitumor efficacy and reduced toxicity of docetaxel using anacardic acid functionalized stealth liposomes. Colloids Surf B Biointerfaces, 2018; 172:213–223.
MeneghiniBC, TavaresER, GuidoMC, et al.: Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model. Vascul Pharmacol, 2019; 115:46–54.
13.
YewaleC, BaradiaD, PatilS, BhattP, AmrutiyaJ, GandhiR, KoreG, MisraA. Docetaxel loaded immunonanoparticles delivery in EGFR overexpressed breast carcinoma cells. J Drug Deliv Sci Technol, 2018; 45:334–345.
14.
ZhangY, XingY, XianM, ShuangS, DongC: Folate-targeting and bovine serum albumin-gated mesoporous silica nanoparticles as a redox-responsive carrier for epirubicin release. New J Chem, 2019; 43:2694–2701.
15.
LatherV, PooniaN, PanditaD: Mesoporous silica nanoparticles: a multifunctional nanocarrier for therapeutic applications, In: Multifunctional Nanocarriers for Contemporary Healthcare Applications. Md. AbulBarkat, HarshitaAB, SarwarB, FarhanJA (eds.), pp. 192–246. IGI Global, Pennsylvania, 2018.
16.
PanditaD, PooniaN, LatherV: Mesoporous silica nanoparticles in drug delivery and targeting. In: NanoBioMedicine. SinghB, KanwarJR, KatareOP (eds.), pp. 267–336. Studium Press, LLC, Houston, TX, 2015.
17.
PooniaN, LatherV, PanditaD: Mesoporous silica nanoparticles: a smart nanosystem for management of breast cancer. Drug Discov Today, 2018; 1:315–332.
18.
ChaudhryZ, SubramaniamS, KhanGM, et al.: Encapsulation and controlled release of resveratrol within functionalised mesoporous silica nanoparticles for prostate cancer therapy. Front Bioeng Biotechnol, 2019; 225:1–7.
19.
ParkS, ParkH, JeongS, YiBG, ParkK, KeyJ: Hyaluronic acid-conjugated mesoporous silica nanoparticles loaded with dual anticancer agents for chemophotodynamic cancer therapy. J Nanomater, 2019; 2019:1–11.
20.
CarniatoF, AlbertiD, LapadulaA, et al.: Multifunctional Gd-based mesoporous silica nanotheranostic for anticancer drug delivery. J Mat Chem B, 2019; 7:3143–3152.
21.
OwensDE, PeppasNA: Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm, 2006; 307:93–102.
22.
ZhouY, QuanG, WuQ, et al.: Mesoporous silica nanoparticles for drug and gene delivery. Acta Pharm Sin B, 2018; 8:165–177.
23.
GaoY, CheX, ZhengC, et al.: Effect of an albumin-coated mesoporous silicon nanoparticle platform for paclitaxel delivery in human lung cancer cell line A549. J Nanomater, 2016; 2016:1–9.
24.
ZhangE, XingR, LiuS, LiP: Current advances in development of new docetaxel formulations. Expert Opin Drug Deliv, 2019; 16:301–312.
25.
FangJ, WangQ, YangG, XiaoX, LiL, YuT: Albumin-MnO2 gated hollow mesoporous silica nanosystem for modulating tumor hypoxia and synergetic therapy of cervical carcinoma. Colloids Surf B Biointerfaces, 2019; 179:250–259.
26.
Vallet-RegiM, ColillaM, Izquierdo-BarbaI, ManzanoM. Mesoporous silica nanoparticles for drug delivery: current insights. Molecules, 2018; 23:47–53.
27.
TsouCJ, HungY, MouCY: Hollow mesoporous silica nanoparticles with tunable shell thickness and pore size distribution for application as broad-ranging pH nanosensor. Micropor Mesopor Mat, 2014; 190:181–188.
28.
SheX, ChenL, LiC, HeC, HeL, KongL: Functionalization of hollow mesoporous silica nanoparticles for improved 5-FU loading. J Nanomater, 2015; 16:1–8.
29.
HuangX, MengX, TangF, et al.: Mesoporous magnetic hollow nanoparticles-protein carriers for lysosome escaping and cytosolic delivery. Nanotechnology, 2008; 19:1–9.
30.
HoJ, DanquahMK, WangH, FordeGM: Protein loaded mesoporous silica spheres as a controlled delivery platform. J Chem Technol Biotechnol, 2008; 83:351–358.
31.
MeiL, ZhangY, ZhengY, et al.: A novel docetaxel-loaded poly (ɛ-Caprolactone)/Pluronic F68 nanoparticle overcoming multidrug resistance for breast cancer treatment. Nanoscale Res Lett, 2009; 4:1530–1539.
32.
SinghB, SinghS: A comprehensive computer program for the study of drug release kinetics from compressed matrices. Indian J Pharm Sci, 1998; 60:358–362.
33.
YadavDK, PawarH, WankhadeS, SureshS: Development of novel docetaxel phospholipid nanoparticles for intravenous administration: quality by design approach. AAPS PharmSciTech, 2015; 16:855–864.
34.
KarimAH, JalilAA, TriwahyonoS, et al.: Amino modified mesostructured silica nanoparticles for efficient adsorption of methylene blue. J Colloid Interface Sci, 2012; 386:307–314.
NairiV, MeddaS, PiluduM, et al.: Interactions between bovine serum albumin and mesoporous silica nanoparticles functionalized with biopolymers. Chem Eng J, 2018; 340:42–50.
37.
LiY, SongF, GuoY, ChengL, ChenQ: Multifunctional amine mesoporous silica spheres modified with multiple amine as carriers for drug release. J Nanomater, 2018; 2018:1–10.
38.
WaniA, MuthuswamyE, SavithraGH, MaoG, BrockS, OupickýD: Surface functionalization of mesoporous silica nanoparticles controls loading and release behavior of mitoxantrone. Pharm Res, 2012; 29:2407–2418.
39.
Dement'evaOV, SenchikhinIN, KartsevaME, et al.: A new method for loading mesoporous silica nanoparticles with drugs: sol-gel synthesis using drug micelles as a template. Colloid J, 2016; 78:586–595.
40.
MishraM, KumarP, RajawatJS, MalikR, SharmaG, ModgilA: Nanotechnology: revolutionizing the science of drug delivery. Curr Pharm Des, 2019; 24:5086–5107.
41.
BorrajoE, Abellan-PoseR, SotoA, et al.: Docetaxel-loaded polyglutamic acid-PEG nanocapsules for the treatment of metastatic cancer. J Control Release, 2016; 238:263–271.
